Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alken Asset Management
from 13F filings
Historical chart of Alken Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Alken Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Alken Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.9M | 2.0k | 1418.23 |
| 2025-06-30 | $3.0M | 2.6k | 1135.74 |
| 2025-03-31 | $3.3M | 2.6k | 1273.00 |
| 2024-12-31 | $2.9M | 2.6k | 1084.79 |
| 2024-09-30 | $1.5M | 1.3k | 1189.23 |
| 2024-06-30 | $1.4M | 1.3k | 1107.69 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1